HFGP Consent Form to Receive 

Zoledronic Acid (Aclasta®) Infusion Consent Form

Patient Details


Zoledronic acid (Aclasta®) is a medication used to strengthen bones and reduce the risk of fractures in conditions such as osteoporosis.

It is given as an intravenous (IV) infusion, usually once every 12 months.

Please read the following information carefully and tick each box to confirm your understanding.

Be careful driving or operating machinery until you know how Aclasta affects you. 

If you are travelling home by car after the infusion, please wait for 15 minutes before you do, or arrange to have someone drive you. 

Treatment Information

Risks and Side Effects

By submitting this form electronically, I acknowledge that this electronic consent is equivalent to my handwritten signature.

Draw signature|Type signatureClear